II
IN8BIO, INC.
SEC filingBiotechnology · New York, NY
Amount raised$20.1Msold at filing
Total offering$40.2M$20.1M still open
Investors in the raise17count reported to the SEC
FiledDec 30, 2025first sale Dec 22, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Luba R. GreenwoodDirector
Lawrence R. LambExecutive Officer
William HoExecutive Officer, Director
Peter S. BrandtDirector
Jeremy R. GraffDirector
Kate R. RochlinExecutive Officer
Emily R. FairbairnDirector
Corinne R. EpperlyDirector
Alan S. RoemerDirector
Patrick McCallExecutive Officer
Executive officers, directors and promoters as listed on the Form D.